November 5, 2020
In oncology, many manufacturers go into niche indications, where there are very specific tumors, and then they opt for..
October 22, 2020
In this two-part blog series, we interview Bart Heeg, Vice President HEOR and Founder at Ingress Health (A Cytel..
October 14, 2020
A credible evidence base is needed to support and document the economic value of new technologies and therapeutic..